BDULF (Bangkok Dusit Medical Services PCL) EBIT: $624 Mil (TTM As of Mar. 2026)


BDULF Bangkok Dusit Medical Services PCL BDULF
65 GF Score
Price $0.56
GF Value $0.98
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bangkok Dusit Medical Services PCL EBIT?

Bangkok Dusit Medical Services PCL BDULF 65 EBIT is $624 Mil as of Mar. 2026. GuruFocus rates BDULF with a GF Score™ of 65/100 and a GF Value™ of $0.98 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Bangkok Dusit Medical Services PCL's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $163 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $624 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bangkok Dusit Medical Services PCL's annualized ROC % for the quarter that ended in Mar. 2026 was 11.75%. Bangkok Dusit Medical Services PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 19.01%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Bangkok Dusit Medical Services PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.86%.

Bangkok Dusit Medical Services PCL  (OTCPK:BDULF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bangkok Dusit Medical Services PCL's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=646.664 * ( 1 - 19.35% )/( (4536.668 + 4337.25)/ 2 )
=521.534516/4436.959
=11.75 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5002.727 - 482.532 - ( 229.356 - max(0, 748.334 - 731.861+229.356))
=4536.668

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4980.723 - 536.988 - ( 251.742 - max(0, 676.871 - 783.356+251.742))
=4337.25

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Bangkok Dusit Medical Services PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=652.72/( ( (3467.323 + max(-27.998, 0)) + (3399.325 + max(-53.498, 0)) )/ 2 )
=652.72/( ( 3467.323 + 3399.325 )/ 2 )
=652.72/3433.324
=19.01 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(368.568 + 108.39 + 25.518) - (482.532 + 6.032 + 41.91)
=-27.998

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(381.641 + 97.622 + 40.416) - (536.988 + 5.985 + 30.204)
=-53.498

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bangkok Dusit Medical Services PCL's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=623.607/9085.079
=6.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Dusit Medical Services PCL EBIT Related Terms

Bangkok Dusit Medical Services PCL EBIT Historical Data

* Premium members only.

The historical data trend for Bangkok Dusit Medical Services PCL's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Dusit Medical Services PCL EBIT Chart

Bangkok Dusit Medical Services PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 337.37 492.22 548.83 608.16 646.69

Bangkok Dusit Medical Services PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.97 139.64 172.25 148.54 163.18

BDULF vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bangkok Dusit Medical Services PCL EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bangkok Dusit Medical Services PCL's EV-to-EBIT falls into.


BDULF
65GF Score
Bangkok Dusit Medical Services PCL BDULF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Dusit Medical Services PCL EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $624 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $624 Mil mean?
Bangkok Dusit Medical Services PCL (BDULF) has a EBIT of $624 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bangkok Dusit Medical Services PCL.
Is Bangkok Dusit Medical Services PCL's EBIT too high?
Bangkok Dusit Medical Services PCL's current EBIT is $624 Mil. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's EBIT compare to HCA and THC?
Bangkok Dusit Medical Services PCL's EBIT of $624 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bangkok Dusit Medical Services PCL. Bangkok Dusit Medical Services PCL's current EBIT is $624 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BDULF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.98, compared to a current price of $0.56 — trading 42.9% below its estimated fair value. The current EBIT is $624 Mil. Bangkok Dusit Medical Services PCL's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDULF), the current EBIT is $624 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bangkok Dusit Medical Services PCL (BDULF) Overvalued in 2026?

Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued. The current stock price of $0.56 is trading 42.9% below its estimated GF Value™ of $0.98. GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.

Key valuation signals for BDULF:

  • EBIT: $624 Mil
  • GF Value™: $0.98 vs. price of $0.56 (42.9% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the BDULF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bangkok Dusit Medical Services PCL Business Description

Address New Petchburi Road, 2, Soi Soonvijai 7, Bang Kapi, Huaykwang, Bangkok, THA, 10310
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
65GF Score

Get the complete analysis for BDULF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$0.98
GF Value